$PETS
PETMED EXPRESS INC

2021 Q4 Form 10-Q Financial Statement

#000143774922002489 Filed on February 04, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4
Revenue $60.72M $65.90M
YoY Change -7.86% 9.98%
Cost Of Revenue $42.99M $46.27M
YoY Change -7.09% 9.6%
Gross Profit $17.73M $19.62M
YoY Change -9.67% 10.88%
Gross Profit Margin 29.19% 29.78%
Selling, General & Admin $11.87M $9.710M
YoY Change 22.22% 5.54%
% of Gross Profit 66.96% 49.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $710.0K $622.0K
YoY Change 14.15% 10.68%
% of Gross Profit 4.01% 3.17%
Operating Expenses $12.58M $10.33M
YoY Change 21.76% 5.79%
Operating Profit $5.147M $9.293M
YoY Change -44.61% 17.16%
Interest Expense $84.00K $70.00K
YoY Change 20.0% -83.33%
% of Operating Profit 1.63% 0.75%
Other Income/Expense, Net $371.0K $418.0K
YoY Change -11.24% -42.11%
Pretax Income $5.518M $9.711M
YoY Change -43.18% 12.21%
Income Tax $1.300M $2.100M
% Of Pretax Income 23.56% 21.62%
Net Earnings $4.257M $7.611M
YoY Change -44.07% 11.27%
Net Earnings / Revenue 7.01% 11.55%
Basic Earnings Per Share $0.21 $0.38
Diluted Earnings Per Share $0.21 $0.38
COMMON SHARES
Basic Shares Outstanding 20.21M 20.09M
Diluted Shares Outstanding 20.33M 20.10M

Balance Sheet

Concept 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $108.9M $106.5M
YoY Change 2.26% 15.26%
Cash & Equivalents $108.9M $106.5M
Short-Term Investments
Other Short-Term Assets $5.086M $4.500M
YoY Change 13.02% 7.14%
Inventory $27.64M $28.20M
Prepaid Expenses
Receivables $1.267M $1.831M
Other Receivables $0.00 $0.00
Total Short-Term Assets $142.9M $141.0M
YoY Change 1.34% 14.86%
LONG-TERM ASSETS
Property, Plant & Equipment $24.67M $25.50M
YoY Change -3.28% -1.6%
Goodwill
YoY Change
Intangibles $860.0K $860.0K
YoY Change 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $25.53M $26.36M
YoY Change -3.18% -1.55%
TOTAL ASSETS
Total Short-Term Assets $142.9M $141.0M
Total Long-Term Assets $25.53M $26.36M
Total Assets $168.4M $167.4M
YoY Change 0.63% 11.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.94M $21.87M
YoY Change 0.3% 31.46%
Accrued Expenses $4.330M $4.400M
YoY Change -1.59% 37.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $26.27M $26.92M
YoY Change -2.44% 29.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $26.27M $26.92M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $27.53M $28.24M
YoY Change -2.54% 29.36%
SHAREHOLDERS EQUITY
Retained Earnings $130.7M $133.0M
YoY Change -1.71% 6.73%
Common Stock $21.00K $20.00K
YoY Change 5.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $140.9M $139.1M
YoY Change
Total Liabilities & Shareholders Equity $168.4M $167.4M
YoY Change 0.63% 11.92%

Cashflow Statement

Concept 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income $4.257M $7.611M
YoY Change -44.07% 11.27%
Depreciation, Depletion And Amortization $710.0K $622.0K
YoY Change 14.15% 10.68%
Cash From Operating Activities $8.706M $6.440M
YoY Change 35.19% 50.12%
INVESTING ACTIVITIES
Capital Expenditures -$294.0K -$660.0K
YoY Change -55.45% -53.19%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$294.0K -$660.0K
YoY Change -55.45% -53.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.063M -5.630M
YoY Change 7.69% 4.26%
NET CHANGE
Cash From Operating Activities 8.706M 6.440M
Cash From Investing Activities -294.0K -660.0K
Cash From Financing Activities -6.063M -5.630M
Net Change In Cash 2.349M 150.0K
YoY Change 1466.0% -105.95%
FREE CASH FLOW
Cash From Operating Activities $8.706M $6.440M
Capital Expenditures -$294.0K -$660.0K
Free Cash Flow $9.000M $7.100M
YoY Change 26.76% 24.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
938000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
130326
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6600000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
5580000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
6356000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
329000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
174000 USD
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
1870000 USD
CY2021Q1 us-gaap Prepaid Taxes
PrepaidTaxes
959000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
142904000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
161187000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24665000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25450000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 USD
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
25525000 USD
CY2021Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
26310000 USD
CY2021Q4 us-gaap Assets
Assets
168429000 USD
CY2021Q1 us-gaap Assets
Assets
187497000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21935000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
39548000 USD
CY2021Q4 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4330000 USD
CY2021Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5387000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26265000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
44935000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2587000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27640000 USD
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
34420000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3216000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4503000 USD
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108911000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118718000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
19000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
39000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1267000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1262000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1281000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
27527000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
46216000 USD
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2021Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2021Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
9000 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
9000 USD
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20957000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20957000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20269000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
345000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
741000 USD
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
us-gaap Investment Income Interest
InvestmentIncomeInterest
243000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
229000 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
287000 USD
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20269000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
21000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10151000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7111000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
130721000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
134141000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
140902000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
141281000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168429000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
187497000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
60717000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
65896000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
207415000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
237536000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42992000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46273000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
148736000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
168110000 USD
CY2021Q4 us-gaap Gross Profit
GrossProfit
17725000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
19623000 USD
us-gaap Gross Profit
GrossProfit
58679000 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7541000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21050000 USD
CY2020Q4 us-gaap Advertising Expense
AdvertisingExpense
3221000 USD
us-gaap Advertising Expense
AdvertisingExpense
15435000 USD
us-gaap Advertising Expense
AdvertisingExpense
17385000 USD
CY2021Q4 us-gaap Depreciation
Depreciation
710000 USD
CY2020Q4 us-gaap Depreciation
Depreciation
622000 USD
us-gaap Depreciation
Depreciation
2051000 USD
us-gaap Depreciation
Depreciation
1791000 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
12578000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
10330000 USD
us-gaap Operating Expenses
OperatingExpenses
40026000 USD
us-gaap Operating Expenses
OperatingExpenses
40226000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
5147000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
9293000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
18653000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
29200000 USD
CY2021Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
84000 USD
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
73000 USD
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
371000 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
418000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
984000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1167000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5518000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9711000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
19637000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30367000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1261000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4603000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6576000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
4257000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
7611000 USD
us-gaap Net Income Loss
NetIncomeLoss
15034000 USD
us-gaap Net Income Loss
NetIncomeLoss
23791000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1266000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1848000 USD
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.18
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20208000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20094000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20165000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20047000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20329000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20104000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20365000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20100000
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.28
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.90
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.84
us-gaap Net Income Loss
NetIncomeLoss
15034000 USD
us-gaap Net Income Loss
NetIncomeLoss
23791000 USD
us-gaap Depreciation
Depreciation
2051000 USD
us-gaap Depreciation
Depreciation
1791000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3040000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2294000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-19000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
353000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
104000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
84000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1216000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1928000 USD
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-6780000 USD
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
10281000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
911000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-0 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1287000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
983000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-17613000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2211000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1188000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
286000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
152000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9781000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21626000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1266000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1848000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18322000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17039000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18322000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17039000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9807000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2739000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
118718000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103762000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
108911000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
106501000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
60717000 USD
CY2021Q4 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
65896000 USD
CY2020Q4 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2021Q4 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-5179000 USD
CY2021Q4 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.079 pure
CY2021Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
60717000 USD
CY2021Q4 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
65896000 USD
CY2020Q4 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2021Q4 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-5179000 USD
CY2021Q4 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.079 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
207415000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
237536000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-30121000 USD
pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.127 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
207415000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
237536000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
-30121000 USD
pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
-0.127 pure
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
4257000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
7611000 USD
us-gaap Net Income Loss
NetIncomeLoss
15034000 USD
us-gaap Net Income Loss
NetIncomeLoss
23791000 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20208000
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20094000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20165000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20047000
CY2021Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
111000
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
190000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
43000
CY2021Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2020Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20329000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20104000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20365000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20100000
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.18
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
205219
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
205219
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
130326
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
108900000 USD
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2021Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
28700000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1300000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2100000 USD
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.229 pure
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.217 pure
CY2021Q4 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
29000 USD
CY2020 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
194000 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
285000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-106000 USD

Files In Submission

Name View Source Status
0001437749-22-002489-index-headers.html Edgar Link pending
0001437749-22-002489-index.html Edgar Link pending
0001437749-22-002489.txt Edgar Link pending
0001437749-22-002489-xbrl.zip Edgar Link pending
ex_330414.htm Edgar Link pending
ex_330415.htm Edgar Link pending
ex_330416.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pets-20211231.xsd Edgar Link pending
pets-20211231_cal.xml Edgar Link unprocessable
pets-20211231_def.xml Edgar Link unprocessable
pets-20211231_lab.xml Edgar Link unprocessable
pets-20211231_pre.xml Edgar Link unprocessable
pets20211231_10q.htm Edgar Link pending
pets20211231_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending